Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action - Nicolas, J M; Hannestad, J; Holden, D (Epilepsia, 2016)
et al.